NCT07412262: A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression

Sponsor: Guangdong Association of Clinical Trials. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer